The inhibition of cell signaling pathways by antitumor ether lipids

被引:89
作者
Arthur, G
Bittman, R [1 ]
机构
[1] CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA
[2] Univ Manitoba, Dept Biochem & Mol Biol, Winnipeg, MB R3E 0W3, Canada
来源
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM | 1998年 / 1390卷 / 01期
关键词
D O I
10.1016/S0005-2760(97)00163-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:85 / 102
页数:18
相关论文
共 157 条
[61]   ANTITUMOR-ACTIVITY OF SRI-62-834, A CYCLIC ETHER ANALOG OF ET-18-OCH3 [J].
HOULIHAN, WJ ;
LEE, ML ;
MUNDER, PG ;
NEMECEK, GM ;
HANDLEY, DA ;
WINSLOW, CM ;
HAPPY, J ;
JAEGGI, C .
LIPIDS, 1987, 22 (11) :884-890
[62]   PHOSPHOLIPID ANTITUMOR AGENTS [J].
HOULIHAN, WJ ;
LOHMEYER, M ;
WORKMAN, P ;
CHEON, SH .
MEDICINAL RESEARCH REVIEWS, 1995, 15 (03) :157-223
[63]   Tyrosine phosphorylation: Past, present and future [J].
Hunter, T .
BIOCHEMICAL SOCIETY TRANSACTIONS, 1996, 24 (02) :307-327
[64]   Ceramide-binding and activation defines protein kinase c-Raf as a ceramide-activated protein kinase [J].
Huwiler, A ;
Brunner, J ;
Hummel, R ;
Vervoordeldonk, M ;
Stabel, S ;
vandenBosch, H ;
Pfeilschifter, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (14) :6959-6963
[65]  
Ihle JN, 1996, ADV CANCER RES, V68, P23, DOI 10.1016/S0065-230X(08)60351-6
[66]   G(BETA-GAMMA) INTERACTIONS WITH PH DOMAINS AND RAS-MAPK SIGNALING PATHWAYS [J].
INGLESE, J ;
KOCH, WJ ;
TOUHARA, K ;
LEFKOWITZ, RJ .
TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (04) :151-156
[67]  
JUNGHAHN I, 1995, ANTICANCER RES, V15, P449
[68]   PHOSPHATIDYLINOSITOL 3-KINASE [J].
KAPELLER, R ;
CANTLEY, LC .
BIOESSAYS, 1994, 16 (08) :565-576
[69]   SUBUNITS-BETA-GAMMA OF HETEROTRIMERIC G-PROTEIN ACTIVATE BETA-2 ISOFORM OF PHOSPHOLIPASE-C [J].
KATZ, A ;
WU, DQ ;
SIMON, MI .
NATURE, 1992, 360 (6405) :686-689
[70]   UNIDIRECTIONAL MEMBRANE UPTAKE OF THE ETHER LIPID ANTINEOPLASTIC AGENT EDELFOSINE BY L1210 CELLS [J].
KELLEY, EE ;
MODEST, EJ ;
BURNS, CP .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (12) :2435-2439